Teva Pharmaceutical Industries Limited (TEVA.TA)
| Previous close | 5,174.00 |
| Open | 5,200.00 |
| Bid | 5,146.00 x 200 |
| Ask | 5,147.00 x 34100 |
| Day's range | 5,138.00 - 5,200.00 |
| 52-week range | 2,637.00 - 5,379.00 |
| Volume | |
| Avg. volume | 1,399,214 |
| Market cap | 58.286B |
| Beta (5Y monthly) | 1.06 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | 28 Nov 2017 |
| 1y target est | N/A |
- Investor's Business Daily
A Week Of Fast-Moving Stocks Ahead: Disney, Toyota, Ferrari, Constellation
As the earnings season moves into final innings, some fast-moving names led by Disney, Ferrari and Constellation are due to report.
- Zacks
Unlocking Q1 Potential of Teva Pharmaceutical Industries (TEVA): Exploring Wall Street Estimates for Key Metrics
Evaluate the expected performance of Teva Pharmaceutical Industries (TEVA) for the quarter ended March 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
- Insider Monkey
Corcept Therapeutics Incorporated (NASDAQ:CORT) Q1 2024 Earnings Call Transcript
Corcept Therapeutics Incorporated (NASDAQ:CORT) Q1 2024 Earnings Call Transcript May 1, 2024 Corcept Therapeutics Incorporated beats earnings expectations. Reported EPS is $0.2503, expectations were $0.21. Corcept Therapeutics Incorporated isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day and thank […]
